Tharimmune, Inc. (THAR)
4.37
+0.23
(+5.56%)
USD |
NASDAQ |
Feb 09, 16:00
4.21
-0.16
(-3.66%)
After-Hours: 07:56
Tharimmune EPS Diluted (Quarterly) : -0.3367 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ETHZilla Corp. | -16.80 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.102M |
| Total Expenses (Quarterly) | 2.102M |
| Enterprise Value | 145.73M |
| Earnings Yield | -89.36% |
| Normalized Earnings Yield | -89.36 |